Cell surface glycolipids and glycoproteins in malignant transformation.
D000818:Animals; D000951:Antigens, Neoplasm / Q000032:analysis; D001789:Blood Group Antigens; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D005347:Fibroblasts / Q000032:analysis; D005353:Fibronectins / Q000502:physiology; D005770:Gastrointestinal Neoplasms / Q000032:analysis; D006023:Glycoproteins / Q000032:analysis* / Q000502:physiology; D006028:Glycosphingolipids / Q000032:analysis* / Q000502:physiology; D006801:Humans; D007938:Leukemia / Q000032:analysis; D008562:Membrane Glycoproteins; D008565:Membrane Proteins / Q000032:analysis; D009369:Neoplasms / Q000276:immunology; D009374:Neoplasms, Experimental / Q000032:analysis; D012142:Respiratory Tract Neoplasms / Q000032:analysis; D012794:Sialic Acids / Q000032:analysis; D012799:Sialyltransferases / Q000032:analysis
D000951:Antigens, Neoplasm; D001789:Blood Group Antigens; D005353:Fibronectins; D006023:Glycoproteins; D006028:Glycosphingolipids; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D012794:Sialic Acids; C016424:epiglycanin protein, mouse; D012799:Sialyltransferases